AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025 [Yahoo! Finance]
AbbVie Inc. (ABBV)
Last abbvie inc. earnings: 5/1 07:43 am
Check Earnings Report
US:NYSE Investor Relations:
investors.abbvie.com/investor-overview
Company Research
Source: Yahoo! Finance
Data to be presented on ABBV-514, a novel CCR8 targeting antibody, in Phase 1 for non-small cell lung cancer, head and neck cancer and other solid tumors. Other presentations highlight key insights into treatment resistance and biomarker identification based on real-world-data analyses. NORTH CHICAGO, Ill. March 26, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that new data from its early oncology research will be showcased across multiple presentations at the upcoming American Association of Cancer Research (AACR) Annual Meeting, April 25-30, 2025 . Presentations include data from novel investigational molecules, ABBV-969 and ABBV-514, across a range of hard-to-treat tumor types. Additionally, new insights on treatment
Read more
Impact Snapshot
Event Time:
ABBV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABBV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABBV alerts
High impacting AbbVie Inc. news events
Weekly update
A roundup of the hottest topics
ABBV
News
- AbbVie to Host First-Quarter 2025 Earnings Conference CallPR Newswire
- Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades. [Yahoo! Finance]Yahoo! Finance
- Regulatory Condition Satisfied for License Agreement between AbbVie and Gubra [Yahoo! Finance]Yahoo! Finance
- SpyGlass Pharma Appoints Chetan Pujara, Ph.D., as Chief Research & Development Officer [Yahoo! Finance]Yahoo! Finance
- AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025PR Newswire
ABBV
Earnings
- 1/31/25 - Beat
ABBV
Sec Filings
- 3/25/25 - Form ARS
- 3/24/25 - Form DEFA14A
- 3/24/25 - Form DEF
- ABBV's page on the SEC website